Group Leader Position in Cancer Immunobiology

Group Leader Position in Cancer Immunobiology VIB Leuven, Belgium Research You will lead a ground-breaking scientific program addressing basic research questions with a pronounced translational potential. You have a collaborative mindset that will allow you to build bridges between existing research groups at VIB and KU Leuven, as well as with other academic centers and the industry. You will focus on novel omics technologies with a research-specific focus on oncology and an unmet patient need. We are particularly interested in researchers working on the cross-talk between tumors and the innate and adaptive immune system. Ideally, the candidate will develop innovative reductionist (i.e. 3D tumoroid models) approaches and unique in vivo models (i.e. mouse genetics, in vivo lineage tracing, PDXs, ) to gain novel mechanistic insights and directly test the clinical relevance of the findings using human clinical samples. A dedicated focus on a specific cancer indication and/or underlying biological process (metastatic dissemination, lymph node involvement, circulating tumor cells or specific tumor & micro-environment interactions, etc. is considered a plus. Your profile You have obtained a PhD degree in the field of the (Bio-) Medical Sciences or another field that provides excellent preparation for the requested research program. You have a strong research profile within the aforementioned research domains and the quality of your research is proven by publications in international leading journals and conferences. You have an interest in outreach and broadly contributing to an exciting scientific environment. Interdisciplinary mindset and keen on collaborating broadly in the center, the department, and the university. You possess organizational skills and have a collaborative attitude. You also possess leadership capacities. You have international research experience. The successful candidate must also be selected as assistant professor at the KUL department of Oncology. Proficiency in English is required. Apply Now Deadline 15 November